Regulatory alignment in FDA expedited pathways for infectious diseases: a decadal review with predictive modeling insights.

Tam NT, Sayed AM, Dadam MN, Elsheikh R, Aziz JMA, Gad AG, Nguyen TTH, Tran P, Zhang Z, Ohmagari N, Huy NT.

Open source

DOI
10.1038/s41598-025-30452-0
Published
2025-12-13
Container
Sci Rep
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-30452-0,
  title = {Regulatory alignment in FDA expedited pathways for infectious diseases: a decadal review with predictive modeling insights.},
  author = {Tam NT and  Sayed AM and  Dadam MN and  Elsheikh R and  Aziz JMA and  Gad AG and  Nguyen TTH and  Tran P and  Zhang Z and  Ohmagari N and  Huy NT.},
  year = {2025},
  journal = {Sci Rep},
  doi = {10.1038/s41598-025-30452-0},
  url = {https://doi.org/10.1038/s41598-025-30452-0}
}

RIS

TY  - JOUR
TI  - Regulatory alignment in FDA expedited pathways for infectious diseases: a decadal review with predictive modeling insights.
AU  - Tam NT
AU  -  Sayed AM
AU  -  Dadam MN
AU  -  Elsheikh R
AU  -  Aziz JMA
AU  -  Gad AG
AU  -  Nguyen TTH
AU  -  Tran P
AU  -  Zhang Z
AU  -  Ohmagari N
AU  -  Huy NT.
PY  - 2025
JO  - Sci Rep
DO  - 10.1038/s41598-025-30452-0
UR  - https://doi.org/10.1038/s41598-025-30452-0
ER  - 

APA

NT, T., AM, S., MN, D., R, E., JMA, A., AG, G., TTH, N., P, T., Z, Z., N, O., & NT., H. (2025). Regulatory alignment in FDA expedited pathways for infectious diseases: a decadal review with predictive modeling insights.. Sci Rep. https://doi.org/10.1038/s41598-025-30452-0

Source records